Page last updated: 2024-10-24

carbamazepine and Degenerative Diseases, Central Nervous System

carbamazepine has been researched along with Degenerative Diseases, Central Nervous System in 3 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Research Excerpts

ExcerptRelevanceReference
"Carbamazepine (CBZ) is an antiepileptic drug, which also could be used in the treatment of neurodegenerative diseases, such as the Alzheimer's disease."7.88PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization. ( Alonso, SDV; IgartĂșa, DE; Martinez, CS; Prieto, MJ; Temprana, CF, 2018)
"Carbamazepine (CBZ) is an antiepileptic drug, which also could be used in the treatment of neurodegenerative diseases, such as the Alzheimer's disease."3.88PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization. ( Alonso, SDV; IgartĂșa, DE; Martinez, CS; Prieto, MJ; Temprana, CF, 2018)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
IgartĂșa, DE1
Martinez, CS1
Temprana, CF1
Alonso, SDV1
Prieto, MJ1
Tobin, WO1
Mathur, SK1
Saini, M1
Bhardwaj, AK1

Reviews

1 review available for carbamazepine and Degenerative Diseases, Central Nervous System

ArticleYear
Management of Multiple Sclerosis Symptoms and Comorbidities.
    Continuum (Minneapolis, Minn.), 2019, Volume: 25, Issue:3

    Topics: Anticonvulsants; Carbamazepine; Cognitive Dysfunction; Comorbidity; Depression; Disease Management;

2019

Other Studies

2 other studies available for carbamazepine and Degenerative Diseases, Central Nervous System

ArticleYear
PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization.
    International journal of pharmaceutics, 2018, Jun-10, Volume: 544, Issue:1

    Topics: Animals; Carbamazepine; Cell Line; Cells, Cultured; Dendrimers; Drug Delivery Systems; Drug Liberati

2018
The lady with a calcified brain.
    BMJ case reports, 2012, Mar-20, Volume: 2012

    Topics: Anticonvulsants; Basal Ganglia Diseases; Calcinosis; Calcium; Carbamazepine; Diagnosis, Differential

2012